These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 13525759)

  • 1. Antigenicity of combined beta-propiolactone and ultraviolet inactivated virus vaccines.
    LOGRIPPO GA
    J Immunol; 1958 Mar; 80(3):198-203. PubMed ID: 13525759
    [No Abstract]   [Full Text] [Related]  

  • 2. Antigenicity of beta-propiolactone-inactivated virus vaccines.
    LOGRIPPO GA; HARTMAN FW
    J Immunol; 1955 Aug; 75(2):123-8. PubMed ID: 13242811
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antigenic and vaccinating power of Newcastle virus inactivated by beta-propiolactone].
    LEPINE P; ATANASIU P
    Ann Inst Pasteur (Paris); 1956 Jul; 91(1):100-2. PubMed ID: 13340335
    [No Abstract]   [Full Text] [Related]  

  • 4. Response of feral cats to vaccination at the time of neutering.
    Fischer SM; Quest CM; Dubovi EJ; Davis RD; Tucker SJ; Friary JA; Crawford PC; Ricke TA; Levy JK
    J Am Vet Med Assoc; 2007 Jan; 230(1):52-8. PubMed ID: 17199493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and reactogenicity of a three-dose primary vaccination course with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-haemophilus influenzae type b vaccine coadministered with a meningococcal C conjugate vaccine.
    Tejedor JC; Omeñaca F; García-Sicilia J; Verdaguer J; Van Esso D; Esporrín C; Molina V; Muro M; Marés J; Enrubia M; Moraga F; García-Corbeira P; Dobbelaere K; Schuerman L;
    Pediatr Infect Dis J; 2004 Dec; 23(12):1109-15. PubMed ID: 15626947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(lactide-co-glycolide) microspheres: a potent oral delivery system to elicit systemic immune response against inactivated rabies virus.
    Ramya R; Verma PC; Chaturvedi VK; Gupta PK; Pandey KD; Madhanmohan M; Kannaki TR; Sridevi R; Anukumar B
    Vaccine; 2009 Mar; 27(15):2138-43. PubMed ID: 19356617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and perspectives on the success of vaccination against bovine herpesvirus-1.
    van Drunen Littel-van den Hurk S
    Vet Microbiol; 2006 Mar; 113(3-4):275-82. PubMed ID: 16330163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs.
    Kyriakis CS; De Vleeschauwer A; Barbé F; Bublot M; Van Reeth K
    Vaccine; 2009 Apr; 27(16):2258-64. PubMed ID: 19428840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of vaccines against bacterial diseases in swine: what can we expect?
    Haesebrouck F; Pasmans F; Chiers K; Maes D; Ducatelle R; Decostere A
    Vet Microbiol; 2004 Jun; 100(3-4):255-68. PubMed ID: 15145504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the immune response of chickens vaccinated with formalin- and beta-propiolactone-inactivated Newcastle disease vaccines.
    APPLETON GS; HITCHNER SB; WINTERFIELD RW
    Am J Vet Res; 1963 Jul; 24():827-31. PubMed ID: 14013488
    [No Abstract]   [Full Text] [Related]  

  • 13. beta-Propiolactone as a toxoiding agent.
    ORLANS ES; JONES VE
    Nature; 1958 Nov; 182(4644):1216-7. PubMed ID: 13590278
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose response effects of avian influenza (H7N7) vaccination of chickens: serology, clinical protection and reduction of virus excretion.
    Maas R; Tacken M; van Zoelen D; Oei H
    Vaccine; 2009 Jun; 27(27):3592-7. PubMed ID: 19464539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a benefit from an early booster vaccination in the control of equine influenza?
    Heldens JG; van Loon AA; van de Zande S
    Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination markers: designing unique antigens to be added to vaccines to differentiate between natural infection and vaccination.
    Root-Bernstein RS
    Vaccine; 2005 Mar; 23(17-18):2057-9. PubMed ID: 15755570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of Newcastle disease by vaccination.
    Senne DA; King DJ; Kapczynski DR
    Dev Biol (Basel); 2004; 119():165-70. PubMed ID: 15742628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of preterm newborns to immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated polio and Haemophilus influenzae type b vaccine: first experiences and solutions to a serious and sensitive issue.
    Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Romero A; Lopez G; Dal-Ré R
    Pediatrics; 2005 Dec; 116(6):1292-8. PubMed ID: 16322149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of anesthesia and surgery on serologic responses to vaccination in kittens.
    Reese MJ; Patterson EV; Tucker SJ; Dubovi EJ; Davis RD; Crawford PC; Levy JK
    J Am Vet Med Assoc; 2008 Jul; 233(1):116-21. PubMed ID: 18593319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants.
    Lin TY; Wang YH; Chang LY; Huang YC; Kao HT; Lin PY; Lu HK; Chavand P; Ortiz E
    Int J Infect Dis; 2007 Mar; 11(2):129-36. PubMed ID: 16762579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.